Details for New Drug Application (NDA): 210778
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 210778
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Pharmacology for NDA: 210778
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 210778
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 210778 | ANDA | GLENMARK PHARMACEUTICALS INC., USA | 68462-605 | 68462-605-27 | 1 CAN in 1 CARTON (68462-605-27) / 50 g in 1 CAN |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 210778 | ANDA | GLENMARK PHARMACEUTICALS INC., USA | 68462-605 | 68462-605-94 | 1 CAN in 1 CARTON (68462-605-94) / 100 g in 1 CAN |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 1% | ||||
Approval Date: | Sep 20, 2021 | TE: | AT | RLD: | No |
Complete Access Available with Subscription